BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Covington
Healthtrust
Moodys
Chubb
Merck
Dow
Federal Trade Commission
UBS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Isosorbide mononitrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for isosorbide mononitrate and what is the scope of isosorbide mononitrate patent protection?

Isosorbide mononitrate
is the generic ingredient in four branded drugs marketed by Schering Plough, Accord Hlthcare, Actavis Elizabeth, Alkermes Gainesville, Dexcel Ltd, Hikma Pharms, Ivax Sub Teva Pharms, Kremers Urban Pharms, Nesher Pharms, Skyepharma Ag, Torrent Pharms, Vintage Pharms, Promius Pharma, and Ani Pharms Inc, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for isosorbide mononitrate. Thirty-one suppliers are listed for this compound.
Pharmacology for isosorbide mononitrate
Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for isosorbide mononitrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075448-001 Jun 19, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Skyepharma Ag ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075166-001 Oct 7, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kremers Urban Pharms MONOKET isosorbide mononitrate TABLET;ORAL 020215-001 Jun 30, 1993 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Promius Pharma ISMO isosorbide mononitrate TABLET;ORAL 019091-001 Dec 30, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering Plough IMDUR isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 020225-001 Aug 12, 1993 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075448-002 Aug 7, 2001 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 076813-001 Jan 7, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alkermes Gainesville ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075041-001 Sep 22, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kremers Urban Pharms MONOKET isosorbide mononitrate TABLET;ORAL 020215-002 Jun 30, 1993 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075306-001 Dec 31, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Cerilliant
AstraZeneca
Johnson and Johnson
Teva
Chubb
QuintilesIMS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot